Literature DB >> 31094127

Prevalence Of Metabolic Syndrome Among Apparently Healthy Workforce.

Mudassar Ali Roomi1, Masoud Mohammadnezhad2.   

Abstract

Metabolic syndrome (MetS) is clustering of various cardiometabolic risk factors and it increases the risk of cardiovascular diseases and diabetes. Unhealthy lifestyle predisposes employees to increased risk of MetS. This systematic review was conducted to investigate the prevalence of MetS and its associated factors among working population. Studies published in English during 2005-2017 on the prevalence of MetS in workforce were searched. MetS was defined using Adult Treatment Panel-III criteria and searches were carried out in various databases using keywords for titles and/or abstracts. Forty articles, containing 435,013 participants aged 38.5 (18-64) years, were finally included. Overall average prevalence of MetS was 21.7% (6.1-58%). Average prevalence of MetS was higher in males (21.9%) than in females (14.1%). Region-wise prevalence of MetS was 27.93% in North America, 27.65% in South America, 21.27% in Asia, 16.04% in Africa, and 10.47% in Europe. Mean prevalence of each component of MetS was 39.1% for low HDL, 33.7% for hypertension, 30.8% for hypertriglyceridemia, 29.2% for central obesity, and 17.6% for hyperglycaemia. Major factors associated with MetS were male gender, aging, inactivity, smoking, stress, elevated liver enzymes, higher education, longer work experience, alcohol abuse, shift work, and lower fruit intake. Prevalence of MetS among workforce was high and it decreases work performance and increases personal and corporate health-care cost. Employees are suggested to enhance physical activity and adopt healthy lifestyle. Employers may increase the cardiometabolic health of their employees by increasing awareness, routine screening for MetS, and by providing various health promotion programs at the worksite.

Entities:  

Keywords:  Cardiometabolic risk; Metabolic syndrome; Obesity; Occupational health

Mesh:

Year:  2019        PMID: 31094127

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  7 in total

1.  Function and Morphology of the Meibomian Glands Using a LipiView Interferometer in Rotating Shift Medical Staff.

Authors:  Jing Zhang; Zhengzheng Wu; Liangnan Sun; Xin-Hua Liu
Journal:  J Ophthalmol       Date:  2020-08-17       Impact factor: 1.909

2.  The Role of H2S in the Metabolism of Glucose and Lipids.

Authors:  Hai-Jian Sun; Zhi-Yuan Wu; Xiao-Wei Nie; Jin-Song Bian
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The Relationship Between the Metabolic Syndrome and the Place of Residence in the Local Community on the Example of the Janów Lubelski District in Eastern Poland: A Population-Based Study.

Authors:  Grzegorz Józef Nowicki; Barbara Ślusarska; Katarzyna Naylor; Andrzej Prystupa; Ewa Rudnicka-Drożak; Ulyana Halyuk; Petro Pokotylo
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-06       Impact factor: 3.168

4.  The Study of Clustering Effects of Behavior Risk Factors in Patients with Metabolic Syndrome in Southern China: A Cross-Sectional Study.

Authors:  Huiwu Han; Fan Zheng; Weiwei Dai; Hua Peng; Shi Zhou; Huixia Tian
Journal:  J Diabetes Res       Date:  2020-07-01       Impact factor: 4.011

5.  Increased Uric Acid and Life Style Factors Associated with Metabolic Syndrome in Thais.

Authors:  Suwit Klongthalay; Kanjana Suriyaprom
Journal:  Ethiop J Health Sci       Date:  2020-03

6.  Magnitude and Associated Factors of Metabolic Syndrome Among Adult Urban Dwellers of Northern Ethiopia.

Authors:  Gebremedhin Gebreegziabiher; Tefera Belachew; Kibriti Mehari; Dessalegn Tamiru
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-10       Impact factor: 3.168

Review 7.  Association between metabolic syndrome and work: an integrative review of the literature.

Authors:  Amália Ivine Costa Santana; Magno Conceição das Merces; Lucélia Batista Neves Cunha Magalhães; André Luiz Brandão Costa; Argemiro D'Oliveira
Journal:  Rev Bras Med Trab       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.